CVD-COVID-UK Consortium

Vaccinating adolescents in England: a risk-benefit analysis

Twitter thread by Deepti Gurdasani Media coverage: “Giving 12 to 17-year-olds two doses of Pfizer’s Covid vaccine could prevent 4,000 hospitalisations and benefits DO outweigh risks, study claims… but experts criticise ‘limited’ findings”.

Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort

Vaccinating adolescents in England: a risk-benefit analysis

Twitter thread by Deepti Gurdasani Media coverage: “Why are government experts holding off vaccinating under-16s in the UK?". Deepti Gurdasani. Guardian. 06/08/2021. “Covid-19: All 16 and 17 year olds in the UK to be offered first vaccine dose”.

Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource